Guide Therapeutics, Inc.

Amendment
CIK: 0001769132·Other Technology·DELAWARE·Filed: Jan 13, 2020
Total Offering

$8,000,000

Amount Sold

$8,000,000

Investors

2

First Sale

Feb 15, 2019

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2018
Non-Accredited Investors
No

Related Persons

NameRole
James Dahlman
Related Person
Julie Sunderland
Related Person
Andrew Perlman
Related Person

Company

Guide Therapeutics, Inc.

1860 MONTREAL ROAD

TUCKER, GA, 30084

509-863-3501

SEC Filing

0001769132-20-000003

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Guide Therapeutics, Inc. Form D Filing — $8,000,000 | FilingFlow